Rankings
▼
Calendar
BSX Q3 2016 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena
BSX
Boston Scientific Corporation
$103B
Q3 2016 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$2.1B
Gross Profit
$1.4B
64.7% margin
Operating Income
$336M
16.0% margin
Net Income
$228M
10.8% margin
EPS (Diluted)
$0.17
QoQ Revenue Growth
-1.0%
Cash Flow
Operating Cash Flow
-$31M
Free Cash Flow
-$102M
Stock-Based Comp.
$29M
Balance Sheet
Total Assets
$17.7B
Total Liabilities
$11.2B
Stockholders' Equity
$6.5B
Cash & Equivalents
$237M
Revenue Segments
Cardiovascular
$2.7B
54%
MedSurg
$2.3B
46%
← FY 2016
All Quarters
Q4 2016 →
